Roche melanoma drug extends life more than a yr-study
More info…
(Reuters) – Roche Holding AG’s new drug for advanced melanoma, Zelboraf, on average helped patients with the deadly disease live for more than a year, according to data from a late-stage trial.
No Comments, add yours